Garnaes, E
Kiss, K
Andersen, L
Therkildsen, M H
Franzmann, M B
Filtenborg-Barnkob, B
Hoegdall, E
Lajer, C B
Andersen, E
Specht, L
Joenson, L
Frederiksen, K
Friis-Hansen, L
Nielsen, F C
Kjaer, S K
Norrild, B
von Buchwald, C
Article History
Received: 22 December 2014
Revised: 24 April 2015
Accepted: 5 May 2015
First Online: 4 June 2015
Competing interests
: EG and CvB received research funding from Sanofi Pasteur MSD (unrestricted grant, 2012). EH received compensation for travel expenses to ASCO from Roche. CBL has received a fee for a lecture from Sanofi Pasteur MSD. LS has a consulting role and has received research funding from Takeda, Merck Serono and Boeringer Ingelheim. SKK received lecture fees, scientific advisory board fees and unrestricted institutional research grants from Merck and Sanofi Pasteur MSD. The remaining authors declare no conflict of interest.